在1.5T MR-Linac系统上使用MR签名匹配 (MRSIGMA) 的实时4DMRI
Can Wu1, Victor Murray1, Syed S Siddiq1
1Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America.
Physics in medicine and biology
|August 24, 2023
概括
这项研究引入了MR签名匹配 (MRSIGMA) 实时4DMRI运动跟踪在胰腺癌患者. MRSIGMA实现了高精度和低不确定性,使精确的体积运动成像能够改善治疗适应性.
科学领域:
- 医学成像医学成像
- 放射治疗物理学的物理学
- 在瘤学瘤学.
背景情况:
- 精确跟踪瘤和器官运动对于有效的放射治疗至关重要.
- 胰腺癌运动在治疗期间对精确瘤向提出了挑战.
- 实时4DMRI可以为适应性放射治疗提供体积运动信息.
研究的目的:
- 开发和评估实时4DMRI,使用MRSIGMA进行体积运动成像.
- 评估MRSIGMA在1.5TMR-Linac系统上的准确性和可行性,用于胰腺癌患者.
- 通过追踪实时呼吸运动,使治疗持续适应.
主要方法:
- 在1.5T MR-Linac.上使用3D黄金角辐射星堆采集的方法开发了MRSIGMA.
- 从最初的MRI扫描中创建了一个4D运动字典,用于签名匹配.
- 实时成像包括将个别的辐射视图与运动跟踪字典相匹配.
主要成果:
- MRSIGMA 显示的总成像延迟不到 300 ms.
- 对于总瘤体积和有风险的器官,获得了High Dice系数 (0.85-0.87),表明了精确的运动跟踪.
- 质量中心偏移很低 (3.1-5.3毫米),随着时间的推移,Dice的得分仍然很高 (0.97).
结论:
- 使用MRSIGMA的实时4DMRI可用于1.5TMR-Linac上的胰腺癌患者的体积运动跟踪.
- MRSIGMA的高精度和低不确定性支持其在适应性放射治疗中的使用.
- 这项技术可以通过优化关键结构附近的剂量输送来提高治疗安全性和有效性.
相关概念视频
Magnetic Resonance Imaging
5.2K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
5.2K
Imaging Studies for Cardiovascular System IV: CMRI
60
Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
60


